Wenger Vieli Ltd is well-equipped to assist with mandates concerning the de-listing of reimbursed products, M&A, and product liability claims. Frank Scherrer leads the team with his longstanding expertise in establishment licences, marketing authorisations, and data protection issues. Marcel Boller is a key contact for pharma companies and pharmacies seeking advice on data exclusivity issues and joint ventures.

Legal 500 Editorial commentary

Work highlights

  • Advising a global pharmaceutical company in relation to the introduction by the regulator of turnover based rebates.
  • Represented a pharmaceutical company in appeal proceedings regarding the deletion of one of its products from the list of reimbursed products.
  • Advised IK Partners on the EUR 370m sale of Klingel medical metal group to Elos Medtech.

Practice head

The lawyer(s) leading their teams.

Frank Scherrer

Other key lawyers

Marcel Boller